p53 mutant human glioma cells are sensitive to UV-C-induced apoptosis due to impaired cyclobutane pyrimidine dimer removal

Molecular Cancer Research

Volumn 7, Issue 2, 2009, Pages 237-246

  Batista, Luis F Z ^a,b   Roos, Wynand P ^b   Kaina, Bernd ^b   Menck, Carlos F M ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN BAK; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P53; PYRIMIDINE DIMER; TEMOZOLOMIDE;

APOPTOSIS; ARTICLE; DNA DAMAGE; DNA REPLICATION; GLIOMA CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DEGRADATION; TRANSCRIPTION REGULATION; ULTRAVIOLET C RADIATION; UPREGULATION;

APOPTOSIS; BCL-2 HOMOLOGOUS ANTAGONIST-KILLER PROTEIN; BCL-2-ASSOCIATED X PROTEIN; BRAIN NEOPLASMS; CASPASES; CELL PROLIFERATION; DNA REPLICATION; FAS-ASSOCIATED DEATH DOMAIN PROTEIN; FLOW CYTOMETRY; GLIOMA; HUMANS; IN SITU NICK-END LABELING; MUTATION; PROTO-ONCOGENE PROTEINS C-BCL-2; PYRIMIDINE DIMERS; RNA, NEOPLASM; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53; ULTRAVIOLET RAYS;

EID: 61349089240     PISSN: 15417786     EISSN: None     Source Type: Journal    
DOI: 10.1158/1541-7786.MCR-08-0428     Document Type: Article

References (39)

1. Avgeropoulos NG, Batchelor TT. New treatment strategies for malignant gliomas. Oncologist 1999;4:209-24.
2. Sathornsumetee S, Rich JN. New treatment strategies for malignant gliomas. Expert Rev Anticancer Ther 2006;6:1087-104.
3. Stupp R, Mason WP, van den Bent MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 2005;352:987-96.
4. 6-methylguanine. Oncogene 2007;26:186-97.
5. 6-methylguanine DNA methyltransferase and p53 status predict temozolomide sensitivity in human malignant glioma cells. J Neurochem 2006;96:766 -76.
6. Fulci G, Ishii N, Van Meir EG. p53 and brain tumors: from gene mutations to gene therapy. Brain Pathol 1998;8:599-613.
7. Batista LF, Roos WP, Christmann M, Menck CF, Kaina B. Differential sensitivity of malignant glioma cells to methylating and chloroethylating anticancer drugs: p53 determines the switch by regulating XPC, DDB2, and DNA double-strand breaks. Cancer Res 2007;67:11886-95.
8. Scharer OD. DNA interstrand crosslinks: natural and drug-induced DNA adducts that induce unique cellular responses. Chem Bio Chem 2005;6:27-32.
9. Friedberg EC. The eureka enzyme: the discovery of DNA polymerase. Nat Rev Mol Cell Biol 2006;7:143-7.
10. Batista LF, Kaina B, Meneghini R, Menck CF. How DNA lesions are turned into powerful killing structures: Insights from UV-induced apoptosis. Mutat Res 2008, doi:10.1016/j mrrev.2008.09.001.
11. Christmann M, Tomicic MT, Roos WP, Kaina B. Mechanisms of human DNA repair: an update. Toxicology 2003;193:3-34.
12. Costa RM, Chigancas V, Galhardo Rda S, Carvalho H, Menck CF. The eukaryotic nucleotide excision repairpathway. Biochimie 2003;85:1083-99.
13. Dunkern TR, Fritz G, Kaina B. Ultraviolet light-induced DNA damage triggers apoptosis in nucleotide excision repair-deficient cells via Bcl-2 decline and caspase-3/-8 activation. Oncogene 2001;20:6026-38.
14. Chigancas V, Batista LF, Brumatti G, Amarante-Mendes GP, Yasui A, Menck CF. Photorepair of RNA polymerase arrest and apoptosis after ultraviolet irradiation in normal and XPB deficient rodent cells. Cell Death Differ 2002;9:1099-107.
15. Chigancas V, Miyaji EN, Muotri AR, et al. Photorepair prevents ultraviolet-induced apoptosis in human cells expressing the marsupial photolyase gene. Cancer Res 2000;60:2458 -63.
16. Ford JM. Regulation of DNA damage recognition and nucleotide excision repair: anotherrole for p53. Mutat Res 2005;577:195-202.
17. Adimoolam S, Ford JM. p53 and DNA damage-inducible expression of the xeroderma pigmentosum group C gene. Proc Natl Acad Sci U S A 2002;99:12985-90.
18. Hwang BJ, Ford JM, Hanawalt PC, Chu G. Expression of the p48 xeroderma pigmentosum gene is p53-dependent and is involved in global genomic repair. Proc Natl Acad Sci U S A 1999;96:424-8.
19. Smith ML, Chen IT, Zhan Q, O'Connor PM, Fornace AJ, Jr. Involvement of the p53 tumor suppressor in repair of U.V.-type DNA damage. Oncogene 1995;10:1053-9.
20. Wischhusen J, Naumann U, Ohgaki H, Rastinejad F, Weller M. CP-31398, a novel p53-stabilizing agent, induces p53-dependent and p53-independent glioma cell death. Oncogene 2003;22:8233 -45.
21. Andressoo JO, Mitchell JR, de Wit J, et al. An Xpd mouse model for the combined xeroderma pigmentosum/Cockayne syndrome exhibiting both cancer predisposition and segmental progeria. Cancer Cell 2006;10:121 -32.
22. Ljungman M, Zhang F. Blockage of RNA polymerase as a possible trigger for U.V. light-induced apoptosis. Oncogene 1996;13:823-31.
23. Batista LF, Chigancas V, Brumatti G, Amarante-Mendes GP, Menck CF. Involvement of DNA replication in ultraviolet-induced apoptosis of mammalian cells. Apoptosis 2006;11:1139-48.
24. Adams JM. Ways of dying: multiple pathways to apoptosis. Genes Dev 2003;17:2481 -95.
25. Chan DC. Mitochondria: dynamic organelles in disease, aging, and development. Cell 2006;125:1241 -52.
26. Steele RJ, Lane DP. p53 in cancer: a paradigm for modern management of cancer. Surgeon 2005;3:197-205.
27. Fan S, Smith ML, Rivet DJ II, et al. Disruption of p53 function sensitizes breast cancer MCF-7 cells to cisplatin and pentoxifylline. Cancer Res 1995;55:1649 -54.
28. El-Mahdy MA, Hamada FM, Wani MA, Zhu Q, Wani AA. p53-degradation by HPV-16 E6 preferentially affects the removal of cyclobutane pyrimidine dimers from non-transcribed strand and sensitizes mammary epithelial cells to UV-irradiation. Mutat Res 2000;459:135-45.
29. Ljungman M, Lane DP. Transcription-guarding the genome by sensing DNA damage. Nat Rev Cancer2004;4:727-37.
30. Dunkern TR, Kaina B. Cell proliferation and DNA breaks are involved in ultraviolet light-induced apoptosis in nucleotide excision repair-deficient Chinese hamstercells. Mol Biol Cell 2002;13:348-61.
31. Carvalho H, da Costa RM, Chigancas V, et al. Effect of cell confluence on ultraviolet light apoptotic responses in DNA repair deficient cells. Mutat Res 2003;544:159-66.
32. Spierings D, McStay G, Saleh M, et al. Connected to death: the (unexpurgated) mitochondrial pathway of apoptosis. Science 2005;310:66-7.
33. Chaturvedi V, Sitailo LA, Qin JZ, et al. Knockdown ofp53 levels in human keratinocytes accelerates Mcl-1 and Bcl-x(L) reduction thereby enhancing UV-light induced apoptosis. Oncogene 2005;24:5299-312.
34. Knezevic D, Zhang W, Rochette PJ, Brash DE. Bcl-2 is the target of a UV-inducible apoptosis switch and a node for UV signaling. Proc Natl Acad Sci U S A 2007;104:11286-91.
35. Steinbach JP, Weller M. Apoptosis in gliomas: molecular mechanisms and therapeutic implications. J Neurooncol 2004;70:245 -54.
36. Ishii N, Maier D, Merlo A, et al. Frequent co-alterations of TP53, p16/CDKN2A, p14ARF, PTEN tumor suppressor genes in human glioma cell lines. Brain Pathol 1999;9:469-79.
37. Tewari M, Dixit VM. Fas- and tumor necrosis factor-induced apoptosis is inhibited by the poxvirus crmA gene product. J Biol Chem 1995;270:3255 -60.
38. Komarova EA, Gudkov AV. Suppression of p53: a new approach to overcome side effects of antitumor therapy. Biochemistry (Mosc) 2000;65:41-8.
39. Balajee AS, May A, Dianov GL, Friedberg EC, Bohr VA. Reduced RNA polymerase II transcription in intact and permeabilized Cockayne syndrome group B cells. Proc Natl Acad Sci U S A 1997;94:4306-11.